SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-08-014512
Filing Date
2008-06-06
Accepted
2008-06-06 14:31:16
Documents
1
Period of Report
2008-06-05

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 4203
  Complete submission text file 0001140361-08-014512.txt   6065
Mailing Address 341 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 341 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Issuer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1

Mailing Address C/O SYMYX TECHNOLOGIES, INC. 3100 CENTRAL EXPRESSWAY SANTA CLARA CA 95051
Business Address
GOLDBY STEVEN D (Reporting) CIK: 0001216626 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-51531 | Film No.: 08885305